An Efficacy and Safety Study of MORAb-003 in Platinum-Resistant or Refractory Relapsed Ovarian Cancer
Clinical trial NCT00738699 · TERMINATED
Trial details
- NCT number
- NCT00738699
- Sponsor
- Morphotek
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-09-01
- Primary completion
- 2011-12-01
- Enrollment
- 415
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.